FDA NEWS

Natalie Cole says she has hepatitis C - USA Today
Natalie Cole has been diagnosed with hepatitis C, according to a statement released by her publicist on Wednesday. NEW YORK (AP) — Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement Wednesday
Source: www.usatoday.com

Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With - MSN MoneyCentral
SEATTLE , July 16 /PRNewswire-FirstCall/ -- Dendreon Corporation DNDN today announced that the Company has initiated a Phase 2 trial of PROVENGE(R) (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for the treatment of prostate
Source: news.moneycentral.msn.com

BioSante Pharmaceuticals Announces FDA Special Protocol Assessment - PR Inside
- BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it successfully has completed and reached an additional agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for its
Source: www.pr-inside.com

Wal-Mart: the new FDA - CNN Money
The giant retailer, along with CVS ( CVS , Fortune 500 ) and Toys 'R Us, announced recently that it plans to stop selling baby bottles containing the chemical bisphenol-A. The question is, why? Bisphenol-A has been widely used since the 1950s. The
Source: money.cnn.com

Mexican officials in US to demand Mexican tomatoes be cleared of - Chicago Tribune
MEXICO CITY (AP) _ Mexico's health secretary says a team of health and agriculture officials has traveled to the United States to demand that Mexican tomatoes be cleared of any suspicion in a recent salmonella outbreak.Jose Angel Cordova says the
Source: www.chicagotribune.com

Selexis Now Offering Rapid-Development of Human Cell Line With FDA - Phramalive.com
New contract service offering rapid development of high performance HEK293 (human) production cell lines enabled by Selexis Genetic Elements(TM) and Selexis SURE(TM) Cell Line Development program GENEVA, July 16, 2008 /PRNewswire/ -- Selexis SA, a
Source: www.pharmalive.com

U.S. FDA staff questions J&J antibiotic studies - Forbes
WASHINGTON, (Reuters) - U.S. drug reviewers have major concerns about effectiveness data supplied by Johnson & Johnson in a bid to win approval for wider use of its Doribax antibiotic, documents released Monday said. The Food and Drug Administration
Source: www.forbes.com

Jazz Pharmaceuticals plans $26M stock sale - MSN MoneyCentral
Jazz Pharmaceuticals Inc. said Wednesday it entered agreements with selected investors to raise about $26 million in a sale of stock and warrants. Palo Alto-based Jazz (NASDAQ:JAZZ) said its costs in connection with the offering are expected to be
Source: news.moneycentral.msn.com